Theo A. Berkhout

2.3k total citations · 1 hit paper
28 papers, 1.9k citations indexed

About

Theo A. Berkhout is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Theo A. Berkhout has authored 28 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Surgery. Recurrent topics in Theo A. Berkhout's work include Chemokine receptors and signaling (10 papers), Lipid Membrane Structure and Behavior (7 papers) and Cell Adhesion Molecules Research (6 papers). Theo A. Berkhout is often cited by papers focused on Chemokine receptors and signaling (10 papers), Lipid Membrane Structure and Behavior (7 papers) and Cell Adhesion Molecules Research (6 papers). Theo A. Berkhout collaborates with scholars based in United Kingdom, United States and Netherlands. Theo A. Berkhout's co-authors include Andreas Ludwig, Pieter H.E. Groot, Paul Säftig, Dieter Hartmann, Stefan Rose‐John, Neil Broadway, Christian Hundhausen, Kitty Moores, Falk Fahrenholz and Karina Reiß and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Theo A. Berkhout

28 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion

2003 588 citations Christian Hundhausen, Theo A. Berkhout et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Theo A. Berkhout United Kingdom	20	923	747	710	299	197	28	1.9k
Elora J. Weringer United States	12	344 0.4×	496 0.7×	1.1k 1.6×	262 0.9×	155 0.8×	14	2.3k
Enrico Arpaia Canada	12	789 0.9×	1.2k 1.6×	909 1.3×	125 0.4×	169 0.9×	20	2.5k
Jinzhao Hou United States	24	880 1.0×	882 1.2×	1.6k 2.3×	193 0.6×	428 2.2×	32	3.1k
Connie L. Finstad United States	29	856 0.9×	527 0.7×	927 1.3×	72 0.2×	221 1.1×	51	2.3k
Cinzia Bizzarri Italy	22	448 0.5×	615 0.8×	673 0.9×	147 0.5×	84 0.4×	34	1.5k
Dayanidhi Raman United States	23	882 1.0×	641 0.9×	1.4k 2.0×	120 0.4×	247 1.3×	43	2.4k
Paul Fischer United States	27	544 0.6×	1.1k 1.5×	1.1k 1.6×	96 0.3×	167 0.8×	55	2.8k
Danielle L. Krebs Canada	21	1.4k 1.5×	1.3k 1.7×	1.1k 1.5×	91 0.3×	343 1.7×	31	2.9k
Barbara J. Brandhuber United States	25	579 0.6×	1.0k 1.4×	1.7k 2.3×	100 0.3×	209 1.1×	37	3.0k
Eric Caldenhoven Netherlands	25	1.4k 1.5×	1.2k 1.6×	1.1k 1.5×	233 0.8×	675 3.4×	35	3.0k

Countries citing papers authored by Theo A. Berkhout

Since Specialization

Citations

This map shows the geographic impact of Theo A. Berkhout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theo A. Berkhout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theo A. Berkhout more than expected).

Fields of papers citing papers by Theo A. Berkhout

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theo A. Berkhout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theo A. Berkhout. The network helps show where Theo A. Berkhout may publish in the future.

Co-authorship network of co-authors of Theo A. Berkhout

This figure shows the co-authorship network connecting the top 25 collaborators of Theo A. Berkhout. A scholar is included among the top collaborators of Theo A. Berkhout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theo A. Berkhout. Theo A. Berkhout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abel, Sören, Christian Hundhausen, Rolf Mentlein, et al.. (2004). The Transmembrane CXC-Chemokine Ligand 16 Is Induced by IFN-γ and TNF-α and Shed by the Activity of the Disintegrin-Like Metalloproteinase ADAM10. The Journal of Immunology. 172(10). 6362–6372. 347 indexed citations

Berkhout, Theo A., Frank E. Blaney, Angela Bridges, et al.. (2003). CCR2: Characterization of the Antagonist Binding Site from a Combined Receptor Modeling/Mutagenesis Approach. Journal of Medicinal Chemistry. 46(19). 4070–4086. 75 indexed citations

Ludwig, Andreas, Theo A. Berkhout, Kitty Moores, Pieter H.E. Groot, & Gayle A. Chapman. (2002). Fractalkine Is Expressed by Smooth Muscle Cells in Response to IFN-γ and TNF-α and Is Modulated by Metalloproteinase Activity. The Journal of Immunology. 168(2). 604–612. 124 indexed citations

Witherington, Jason, Vincent Bordas, Ian T. Forbes, et al.. (2001). Conformationally Restricted Indolopiperidine Derivatives as Potent CCR2B Receptor Antagonists. Bioorganic & Medicinal Chemistry Letters. 11(16). 2177–2180. 35 indexed citations

Forbes, Ian T., David G. Cooper, Deirdre M. B. Hickey, et al.. (2000). CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound. Bioorganic & Medicinal Chemistry Letters. 10(16). 1803–1806. 41 indexed citations

Berkhout, Theo A., Paula González, Kitty Moores, et al.. (2000). Selective binding of the truncated form of the chemokine CKβ8 (25–99) to CC chemokine receptor 1 (CCR1). Biochemical Pharmacology. 59(5). 591–596. 12 indexed citations

Chapman, Gayle A., Kitty Moores, Theo A. Berkhout, et al.. (2000). The role of fractalkine in the recruitment of monocytes to the endothelium. European Journal of Pharmacology. 392(3). 189–195. 81 indexed citations

Macphee, Colin H., Edward R. Appelbaum, Kyung Johanson, et al.. (1998). Identification of a Truncated Form of the CC Chemokine CKβ-8 Demonstrating Greatly Enhanced Biological Activity. The Journal of Immunology. 161(11). 6273–6279. 23 indexed citations

Pearce, Neil, John Yates, Theo A. Berkhout, et al.. (1998). The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Biochemical Journal. 334(1). 113–119. 124 indexed citations

10.

Berkhout, Theo A., Henry M. Sarau, Kitty Moores, et al.. (1997). Cloning, in Vitro Expression, and Functional Characterization of a Novel Human CC Chemokine of the Monocyte Chemotactic Protein (MCP) Family (MCP-4) That Binds and Signals through the CC Chemokine Receptor 2B. Journal of Biological Chemistry. 272(26). 16404–16413. 88 indexed citations

11.

Berkhout, Theo A., Brian Jackson, John Yates, et al.. (1997). SR-12813 lowers plasma cholesterol in beagle dogs by decreasing cholesterol biosynthesis. Atherosclerosis. 133(2). 203–212. 19 indexed citations

12.

Berkhout, Theo A., Dilip D. Patel, C. Bentzen, et al.. (1996). The Novel Cholesterol-lowering Drug SR-12813 Inhibits Cholesterol Synthesis via an Increased Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase. Journal of Biological Chemistry. 271(24). 14376–14382. 35 indexed citations

13.

Mayer, Ruth J., Jerry L. Adams, M.J. Bossard, & Theo A. Berkhout. (1991). Effects of a novel lanosterol 14 alpha-demethylase inhibitor on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in Hep G2 cells.. Journal of Biological Chemistry. 266(30). 20070–20078. 31 indexed citations

14.

Berkhout, Theo A., Louis M. Havekes, Neil Pearce, & Pieter H.E. Groot. (1990). The effect of (−)-hydroxycitrate on the activity of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase levels in the human hepatoma cell line Hep G2. Biochemical Journal. 272(1). 181–186. 73 indexed citations

15.

Berkhout, Theo A., et al.. (1986). Preferential association of apocytochrome c with negatively charged phospholipids in mixed model membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 858(1). 38–46. 38 indexed citations

16.

Berkhout, Theo A., et al.. (1985). Coupling of photoactivatable glycolipid probes to apolipoproteins A-I and A-II in human high density lipoproteins 2 and 3.. Journal of Lipid Research. 26(8). 964–969. 2 indexed citations

17.

Berkhout, Theo A., Antonie J. W. G. Visser, & K.W.A. Wirtz. (1984). Static and time-resolved fluorescence studies of fluorescent phosphatidylcholine bound to the phosphatidylcholine-transfer protein of bovine liver. Biochemistry. 23(7). 1505–1513. 30 indexed citations

18.

Berkhout, Theo A., et al.. (1984). Labeling of phospholipids in vesicles and human erythrocytes by photoactivable fatty acid derivatives. European Journal of Biochemistry. 142(1). 91–97. 12 indexed citations

19.

Westerman, Jan, et al.. (1983). Identification of the Lipid-Binding Site of Phosphatidylcholine-Transfer Protein with Phosphatidylcholine Analogs Containing Photactivable Carbene Precursors. European Journal of Biochemistry. 132(2). 441–449. 41 indexed citations

20.

Pastink, Albert, et al.. (1979). Analysis of histones from the yeast Saccharomyces carlsbergensis. Biochemical Journal. 177(3). 917–923. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact